While these are the classic signs, not all symptoms of the deadly ... exposure to certain toxins and family history. Two major types of lung cancer are non-small cell lung cancer and small cell ...

TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Pasi A. Jänne, M.D., PhD, a world renowned translational thoracic medical oncologist, to its Scientific Advisory Board (SAB).

Figures published by the Welsh Cancer Intelligence and Surveillance Unit show the percentage of people surviving one year ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared ...

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, reported recent activity at major scientific gatherings and announc ...

Modern lifestyles have brought convenience but also hidden health risks. One worrying statistic stands out; breast cancer rates in women under 50 have steadily increased by 1.4 percent ...

This progressive lung disease transforms healthy tissue into stiff, scarred areas making breathing difficult. Learn the warning signs and treatment options.

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Nadunolimab's additional potential in mitigating neuropathy demonstrated by data from Cantargia's CESTAFOUR and CAPAFOUR clinical studiesPotential neuroprotective effect ...

Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...